found that the combination of CDH17 and CLDN18 demonstrates homogeneous and robust expression in more than 90% of GC cases, and their coupling is helpful to detect and localise GC metastasis in vivo, which provides a possibility to overcome the challenge of intratumoural heterogeneity (52). Here, CLDN18 is linked to gastric cancer.